Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery.

about

Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery.

Item

http://www.wikidata.org/entity/Q55037159

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Prognostic Role of High-sensit ...... ndergoing Non-cardiac Surgery.

@en

Prognostic Role of High-sensit ...... ndergoing Non-cardiac Surgery.

@nl

type

Item

label

Prognostic Role of High-sensit ...... ndergoing Non-cardiac Surgery.

@en

Prognostic Role of High-sensit ...... ndergoing Non-cardiac Surgery.

@nl

prefLabel

Prognostic Role of High-sensit ...... ndergoing Non-cardiac Surgery.

@en

Prognostic Role of High-sensit ...... ndergoing Non-cardiac Surgery.

@nl

P1476

Prognostic Role of High-sensit ...... ndergoing Non-cardiac Surgery.

@en

P2093

Ahram Yi

http://www.w3.org/2001/XMLSchema#string

Hanah Kim

http://www.w3.org/2001/XMLSchema#string

Jayoun Kim

http://www.w3.org/2001/XMLSchema#string

Mina Hur

http://www.w3.org/2001/XMLSchema#string

P2860

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.

Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery.

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of A

Soluble ST2 has a prognostic role in patients with suspected sepsis.

Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis.

Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk.

Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study).

Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction.

The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention.

P304

204-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3343/ALM.2018.38.3.204

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hyun Suk Yang

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29401554

http://www.w3.org/2001/XMLSchema#string

P921

intensive care unit

P932

5820064

http://www.w3.org/2001/XMLSchema#string